Jpmorgan Chase & CO Nutri Band Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Nutri Band Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12 shares of NTRB stock, worth $81. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 12
-0.0%
Holding current value
$81
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NTRB
# of Institutions
16Shares Held
251KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA125KShares$842,2280.0% of portfolio
-
Geode Capital Management, LLC Boston, MA62.4KShares$422,0600.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$116,7180.0% of portfolio
-
Avantax Advisory Services, Inc.13.6KShares$92,2530.0% of portfolio
-
Haven Private, LLC Orlando, FL11.6KShares$78,1520.03% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $52.8M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...